Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912761243> ?p ?o ?g. }
- W2912761243 endingPage "323" @default.
- W2912761243 startingPage "323" @default.
- W2912761243 abstract "Intensive research is underway to find new agents that can successfully mitigate the acute effects of radiation exposure. This is primarily in response to potential counterthreats of radiological terrorism and nuclear accidents but there is some hope that they might also be of value for cancer patients treated with radiation therapy. Research into mitigation countermeasures typically employs classic animal models of acute radiation syndromes (ARS) that develop after whole-body irradiation (WBI). While agents are available that successfully mitigate ARS when given after radiation exposure, their success raises questions as to whether they simply delay lethality or unmask potentially lethal radiation pathologies that may appear later in time. Life shortening is a well-known consequence of WBI in humans and experimental animals, but it is not often examined in a mitigation setting and its causes, other than cancer, are not well-defined. This is in large part because delayed effects of acute radiation exposure (DEARE) do not follow the strict time–dose phenomena associated with ARS and present as a diverse range of symptoms and pathologies with low mortality rates that can be evaluated only with the use of large cohorts of subjects, as in this study. Here, we describe chronically increased mortality rates up to 660 days in large numbers of mice given LD70/30 doses of WBI. Systemic myeloid cell activation after WBI persists in some mice and is associated with late immunophenotypic changes and hematopoietic imbalance. Histopathological changes are largely of a chronic inflammatory nature and variable incidence, as are the clinical symptoms, including late diarrhea that correlates temporally with changes in the content of the microbiome. We also describe the acute and long-term consequences of mitigating hematopoietic ARS (H-ARS) lethality after LD70/30 doses of WBI in multiple cohorts of mice treated uniformly with radiation mitigators that have a common 4-nitro-phenylsulfonamide (NPS) pharmacophore. Effective NPS mitigators dramatically decrease ARS mortality. There is slightly increased subacute mortality, but the rate of late mortalities is slowed, allowing some mice to live a normal life span, which is not the case for WBI controls. The study has broad relevance to radiation late effects and their potential mitigation and epitomizes the complex interaction between radiation-damaged tissues and immune homeostasis." @default.
- W2912761243 created "2019-02-21" @default.
- W2912761243 creator A5002701262 @default.
- W2912761243 creator A5004954855 @default.
- W2912761243 creator A5015058243 @default.
- W2912761243 creator A5031719555 @default.
- W2912761243 creator A5035869159 @default.
- W2912761243 creator A5036220506 @default.
- W2912761243 creator A5037040516 @default.
- W2912761243 creator A5039359662 @default.
- W2912761243 creator A5039693749 @default.
- W2912761243 creator A5039906270 @default.
- W2912761243 creator A5045676945 @default.
- W2912761243 creator A5051966528 @default.
- W2912761243 creator A5053939485 @default.
- W2912761243 creator A5056910877 @default.
- W2912761243 creator A5064589097 @default.
- W2912761243 creator A5068820949 @default.
- W2912761243 creator A5073896166 @default.
- W2912761243 creator A5077680507 @default.
- W2912761243 creator A5081282545 @default.
- W2912761243 date "2019-02-07" @default.
- W2912761243 modified "2023-10-10" @default.
- W2912761243 title "The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation" @default.
- W2912761243 cites W1887169756 @default.
- W2912761243 cites W1914345907 @default.
- W2912761243 cites W1978489126 @default.
- W2912761243 cites W1989241623 @default.
- W2912761243 cites W1994049904 @default.
- W2912761243 cites W2004240996 @default.
- W2912761243 cites W2009490797 @default.
- W2912761243 cites W2012368150 @default.
- W2912761243 cites W2012376370 @default.
- W2912761243 cites W2015468874 @default.
- W2912761243 cites W2017165912 @default.
- W2912761243 cites W2024169861 @default.
- W2912761243 cites W2024807294 @default.
- W2912761243 cites W2025503091 @default.
- W2912761243 cites W2026212073 @default.
- W2912761243 cites W2027072863 @default.
- W2912761243 cites W2030795773 @default.
- W2912761243 cites W2039149963 @default.
- W2912761243 cites W2048174295 @default.
- W2912761243 cites W2050838768 @default.
- W2912761243 cites W2057858743 @default.
- W2912761243 cites W2061607163 @default.
- W2912761243 cites W2066853142 @default.
- W2912761243 cites W2068510084 @default.
- W2912761243 cites W2072202016 @default.
- W2912761243 cites W2072600933 @default.
- W2912761243 cites W2074292877 @default.
- W2912761243 cites W2081596206 @default.
- W2912761243 cites W2085821308 @default.
- W2912761243 cites W2088792252 @default.
- W2912761243 cites W2089168706 @default.
- W2912761243 cites W2093617531 @default.
- W2912761243 cites W2102821077 @default.
- W2912761243 cites W2103519814 @default.
- W2912761243 cites W2103589112 @default.
- W2912761243 cites W2106882281 @default.
- W2912761243 cites W2108156549 @default.
- W2912761243 cites W2117898603 @default.
- W2912761243 cites W2122558365 @default.
- W2912761243 cites W2125569782 @default.
- W2912761243 cites W2125924455 @default.
- W2912761243 cites W2127826761 @default.
- W2912761243 cites W2130209511 @default.
- W2912761243 cites W2130927464 @default.
- W2912761243 cites W2132920667 @default.
- W2912761243 cites W2140231263 @default.
- W2912761243 cites W2152101898 @default.
- W2912761243 cites W2159130208 @default.
- W2912761243 cites W2168346590 @default.
- W2912761243 cites W2170504977 @default.
- W2912761243 cites W2175292127 @default.
- W2912761243 cites W2259628957 @default.
- W2912761243 cites W229910295 @default.
- W2912761243 cites W2323567249 @default.
- W2912761243 cites W2345507899 @default.
- W2912761243 cites W2413445006 @default.
- W2912761243 cites W2468926408 @default.
- W2912761243 cites W2522359965 @default.
- W2912761243 cites W2530406573 @default.
- W2912761243 cites W2559212833 @default.
- W2912761243 cites W2569460261 @default.
- W2912761243 cites W2572324726 @default.
- W2912761243 cites W2586127268 @default.
- W2912761243 cites W2618094377 @default.
- W2912761243 cites W2626072088 @default.
- W2912761243 cites W2649908545 @default.
- W2912761243 cites W2733154631 @default.
- W2912761243 cites W2739367335 @default.
- W2912761243 cites W4300327066 @default.
- W2912761243 cites W4300504882 @default.
- W2912761243 cites W2025705858 @default.
- W2912761243 doi "https://doi.org/10.1667/rr15231.1" @default.
- W2912761243 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6482953" @default.
- W2912761243 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30730284" @default.